Ventris Launches Next Generation Allocell AF Biologic

Ventris Allocell AF

Ventris Medical announced the first use of Allocell® AF, a next generation osteoinductive fiber allograft.

Allocell AF was developed for enhanced intra-operative handling and increased biologic responsiveness at the defect site. Allocell AF is designed with broad, augmented bone fibers that maximize the surface area, allowing the fibers to...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us